3.12
Black Diamond Therapeutics Inc Aktie (BDTX) Neueste Nachrichten
Black Diamond Therapeutics Inc. Stock Analysis and ForecastSignificant capital appreciation - PrintWeekIndia
Is Black Diamond Therapeutics Inc. a good long term investmentRecord-breaking gains - PrintWeekIndia
What analysts say about Black Diamond Therapeutics Inc. stockGame-changing capital returns - Autocar Professional
Why Black Diamond Therapeutics Inc. stock attracts strong analyst attentionFree Stock Market Forecasting Tools - Newser
What drives Black Diamond Therapeutics Inc. stock priceMarket-leading capital gains - Autocar Professional
Black Diamond Therapeutics, Inc. (BDTX) Rated Outperform as Lead Drug Shows Promise - MSN
why edgewise therapeutics inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser
Black Diamond Therapeutics discloses EGFR inhibitors for cancer - BioWorld MedTech
How Black Diamond Therapeutics Inc. stock performs during market volatilityMarket Beating Strategy - Newser
What makes Black Diamond Therapeutics Inc. stock price move sharplyGroup Only Stock Signals - Newser
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Consensus Rating of “Buy” from Analysts - Defense World
10 Best Get Rich Quick Stocks to Buy Now - Insider Monkey
Black Diamond Therapeutics, Inc.(NasdaqGS: BDTX) dropped from Russell 2500 Index - MarketScreener
Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) dropped from Russell 2500 Value Index - MarketScreener
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Holdings Boosted by Bank of America Corp DE - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Average Rating of “Buy” from Analysts - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded at Wall Street Zen - Defense World
Black Diamond’s 2025 Annual Stockholders Meeting Highlights - TipRanks
Black Diamond Therapeutics: Targeted Approach And Early Efficacy Signals Create Potential For Significant Upside - Seeking Alpha
Wellington Management Group LLP Grows Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Squarepoint Ops LLC Buys 72,688 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Downgraded to Hold Rating by Wall Street Zen - Defense World
Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Nuveen Asset Management LLC - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Purchased by Millennium Management LLC - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Northern Trust Corp - Defense World
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference - GlobeNewswire
17,317 Shares in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Bought by D. E. Shaw & Co. Inc. - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):